TrialBritish journal of haematology2021

Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105).

Dai Maruyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.